(AMAT) Applied Materials - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0382221051
Stock:
Total Rating 81
Risk 87
Buy Signal 0.91
| Risk 5d forecast | |
|---|---|
| Volatility | 51.8% |
| Relative Tail Risk | -7.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.01 |
| Alpha | 96.39 |
| Character TTM | |
|---|---|
| Beta | 1.774 |
| Beta Downside | 1.978 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.88% |
| CAGR/Max DD | 0.96 |
EPS (Earnings per Share)
Revenue
Description: AMAT Applied Materials
Applied Materials, Inc. provides materials engineering solutions, equipment, services, and software to the semiconductor and related industries in the United States, China, Korea, Taiwan, Japan, Southeast Asia, Europe, and internationally. The company operates through Semiconductor Systems and Applied Global Services (AGS) segments. The Semiconductor Systems segment includes semiconductor capital equipment to enable materials engineering steps, including etch, rapid thermal processing, deposition, chemical mechanical planarization, metrology and inspection, wafer packaging, and ion implantation. The AGS segment offers integrated solutions to optimize equipment and fab performance and productivity comprising spares, upgrades, services, and 200 millimeter and other equipment and factory automation software for semiconductor and other products. It serves manufacturers of semiconductor wafers and chips, and other electronic devices. Applied Materials, Inc. was incorporated in 1967 and is headquartered in Santa Clara, California.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 7.84b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -1.35 > 1.0 |
| NWC/Revenue: 47.13% < 20% (prev 46.89%; Δ 0.24% < -1%) |
| CFO/TA 0.23 > 3% & CFO 8.72b > Net Income 7.84b |
| Net Debt (-28.0m) to EBITDA (9.89b): -0.00 < 3 |
| Current Ratio: 2.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (799.0m) vs 12m ago -2.44% < -2% |
| Gross Margin: 48.72% > 18% (prev 0.48%; Δ 4825 % > 0.5%) |
| Asset Turnover: 79.50% > 50% (prev 82.89%; Δ -3.40% > 0%) |
| Interest Coverage Ratio: 35.60 > 6 (EBITDA TTM 9.89b / Interest Expense TTM 274.0m) |
Altman Z'' 10.00
| A: 0.35 (Total Current Assets 21.05b - Total Current Liabilities 7.75b) / Total Assets 37.64b |
| B: 1.51 (Retained Earnings 56.89b / Total Assets 37.64b) |
| C: 0.27 (EBIT TTM 9.75b / Avg Total Assets 35.49b) |
| D: 3.57 (Book Value of Equity 56.79b / Total Liabilities 15.93b) |
| Altman-Z'' Score: 12.83 = AAA |
Beneish M -3.11
| DSRI: 0.81 (Receivables 4.98b/6.05b, Revenue 28.21b/27.64b) |
| GMI: 0.98 (GM 48.72% / 47.73%) |
| AQI: 1.18 (AQ_t 0.31 / AQ_t-1 0.26) |
| SGI: 1.02 (Revenue 28.21b / 27.64b) |
| TATA: -0.02 (NI 7.84b - CFO 8.72b) / TA 37.64b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of AMAT shares?
As of February 28, 2026, the stock is trading at USD 372.30 with a total of 8,991,766 shares traded.
Over the past week, the price has changed by -0.82%, over one month by +12.04%, over three months by +47.78% and over the past year by +139.81%.
Over the past week, the price has changed by -0.82%, over one month by +12.04%, over three months by +47.78% and over the past year by +139.81%.
Is AMAT a buy, sell or hold?
Applied Materials has received a consensus analysts rating of 4.21.
Therefore, it is recommended to buy AMAT.
- StrongBuy: 21
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AMAT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 409.2 | 9.9% |
| Analysts Target Price | 409.2 | 9.9% |
AMAT Fundamental Data Overview February 28, 2026
P/E Trailing = 38.4565
P/E Forward = 22.9358
P/S = 10.5683
P/B = 9.1326
P/EG = 2.2506
Revenue TTM = 28.21b USD
EBIT TTM = 9.75b USD
EBITDA TTM = 9.89b USD
Long Term Debt = 6.46b USD (from longTermDebt, last fiscal year)
Short Term Debt = 201.0m USD (from shortTermDebt, last quarter)
Debt = 7.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -28.0m USD (from netDebt column, last quarter)
Enterprise Value = 296.85b USD (298.18b + Debt 7.19b - CCE 8.51b)
Interest Coverage Ratio = 35.60 (Ebit TTM 9.75b / Interest Expense TTM 274.0m)
EV/FCF = 47.93x (Enterprise Value 296.85b / FCF TTM 6.19b)
FCF Yield = 2.09% (FCF TTM 6.19b / Enterprise Value 296.85b)
FCF Margin = 21.95% (FCF TTM 6.19b / Revenue TTM 28.21b)
Net Margin = 27.78% (Net Income TTM 7.84b / Revenue TTM 28.21b)
Gross Margin = 48.72% ((Revenue TTM 28.21b - Cost of Revenue TTM 14.47b) / Revenue TTM)
Gross Margin QoQ = 48.99% (prev 48.01%)
Tobins Q-Ratio = 7.89 (Enterprise Value 296.85b / Total Assets 37.64b)
Interest Expense / Debt = 0.96% (Interest Expense 69.0m / Debt 7.19b)
Taxrate = 12.97% (302.0m / 2.33b)
NOPAT = 8.49b (EBIT 9.75b * (1 - 12.97%))
Current Ratio = 2.71 (Total Current Assets 21.05b / Total Current Liabilities 7.75b)
Debt / Equity = 0.33 (Debt 7.19b / totalStockholderEquity, last quarter 21.72b)
Debt / EBITDA = -0.00 (Net Debt -28.0m / EBITDA 9.89b)
Debt / FCF = -0.00 (Net Debt -28.0m / FCF TTM 6.19b)
Total Stockholder Equity = 20.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.09% (Net Income 7.84b / Total Assets 37.64b)
RoE = 38.90% (Net Income TTM 7.84b / Total Stockholder Equity 20.15b)
RoCE = 36.66% (EBIT 9.75b / Capital Employed (Equity 20.15b + L.T.Debt 6.46b))
RoIC = 32.67% (NOPAT 8.49b / Invested Capital 25.99b)
WACC = 12.18% (E(298.18b)/V(305.37b) * Re(12.45%) + D(7.19b)/V(305.37b) * Rd(0.96%) * (1-Tc(0.13)))
Discount Rate = 12.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.77%
[DCF] Terminal Value 64.71% ; FCFF base≈6.09b ; Y1≈6.19b ; Y5≈6.79b
[DCF] Fair Price = 82.55 (EV 65.48b - Net Debt -28.0m = Equity 65.51b / Shares 793.6m; r=12.18% [WACC]; 5y FCF grow 1.48% → 2.90% )
EPS Correlation: 87.52 | EPS CAGR: 6.95% | SUE: 3.33 | # QB: 15
Revenue Correlation: 78.61 | Revenue CAGR: 3.14% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=2.68 | Chg7d=+0.000 | Chg30d=+0.402 | Revisions Net=+25 | Analysts=28
EPS current Year (2026-10-31): EPS=11.05 | Chg7d=-0.015 | Chg30d=+1.423 | Revisions Net=+30 | Growth EPS=+17.3% | Growth Revenue=+10.7%
EPS next Year (2027-10-31): EPS=13.79 | Chg7d=+0.153 | Chg30d=+1.967 | Revisions Net=+30 | Growth EPS=+24.8% | Growth Revenue=+18.7%
[Analyst] Revisions Ratio: +1.00 (25 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.8% (Discount Rate 12.4% - Earnings Yield 2.6%)
[Growth] Growth Spread = -1.8% (Analyst 8.0% - Implied 9.8%)
P/E Forward = 22.9358
P/S = 10.5683
P/B = 9.1326
P/EG = 2.2506
Revenue TTM = 28.21b USD
EBIT TTM = 9.75b USD
EBITDA TTM = 9.89b USD
Long Term Debt = 6.46b USD (from longTermDebt, last fiscal year)
Short Term Debt = 201.0m USD (from shortTermDebt, last quarter)
Debt = 7.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -28.0m USD (from netDebt column, last quarter)
Enterprise Value = 296.85b USD (298.18b + Debt 7.19b - CCE 8.51b)
Interest Coverage Ratio = 35.60 (Ebit TTM 9.75b / Interest Expense TTM 274.0m)
EV/FCF = 47.93x (Enterprise Value 296.85b / FCF TTM 6.19b)
FCF Yield = 2.09% (FCF TTM 6.19b / Enterprise Value 296.85b)
FCF Margin = 21.95% (FCF TTM 6.19b / Revenue TTM 28.21b)
Net Margin = 27.78% (Net Income TTM 7.84b / Revenue TTM 28.21b)
Gross Margin = 48.72% ((Revenue TTM 28.21b - Cost of Revenue TTM 14.47b) / Revenue TTM)
Gross Margin QoQ = 48.99% (prev 48.01%)
Tobins Q-Ratio = 7.89 (Enterprise Value 296.85b / Total Assets 37.64b)
Interest Expense / Debt = 0.96% (Interest Expense 69.0m / Debt 7.19b)
Taxrate = 12.97% (302.0m / 2.33b)
NOPAT = 8.49b (EBIT 9.75b * (1 - 12.97%))
Current Ratio = 2.71 (Total Current Assets 21.05b / Total Current Liabilities 7.75b)
Debt / Equity = 0.33 (Debt 7.19b / totalStockholderEquity, last quarter 21.72b)
Debt / EBITDA = -0.00 (Net Debt -28.0m / EBITDA 9.89b)
Debt / FCF = -0.00 (Net Debt -28.0m / FCF TTM 6.19b)
Total Stockholder Equity = 20.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.09% (Net Income 7.84b / Total Assets 37.64b)
RoE = 38.90% (Net Income TTM 7.84b / Total Stockholder Equity 20.15b)
RoCE = 36.66% (EBIT 9.75b / Capital Employed (Equity 20.15b + L.T.Debt 6.46b))
RoIC = 32.67% (NOPAT 8.49b / Invested Capital 25.99b)
WACC = 12.18% (E(298.18b)/V(305.37b) * Re(12.45%) + D(7.19b)/V(305.37b) * Rd(0.96%) * (1-Tc(0.13)))
Discount Rate = 12.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.77%
[DCF] Terminal Value 64.71% ; FCFF base≈6.09b ; Y1≈6.19b ; Y5≈6.79b
[DCF] Fair Price = 82.55 (EV 65.48b - Net Debt -28.0m = Equity 65.51b / Shares 793.6m; r=12.18% [WACC]; 5y FCF grow 1.48% → 2.90% )
EPS Correlation: 87.52 | EPS CAGR: 6.95% | SUE: 3.33 | # QB: 15
Revenue Correlation: 78.61 | Revenue CAGR: 3.14% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=2.68 | Chg7d=+0.000 | Chg30d=+0.402 | Revisions Net=+25 | Analysts=28
EPS current Year (2026-10-31): EPS=11.05 | Chg7d=-0.015 | Chg30d=+1.423 | Revisions Net=+30 | Growth EPS=+17.3% | Growth Revenue=+10.7%
EPS next Year (2027-10-31): EPS=13.79 | Chg7d=+0.153 | Chg30d=+1.967 | Revisions Net=+30 | Growth EPS=+24.8% | Growth Revenue=+18.7%
[Analyst] Revisions Ratio: +1.00 (25 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.8% (Discount Rate 12.4% - Earnings Yield 2.6%)
[Growth] Growth Spread = -1.8% (Analyst 8.0% - Implied 9.8%)